MentorcliQ (Brand Name or Equal)

Notice ID:

FDA-RFQ-22-1249591

Department/Ind. Agency:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub Command:

FDA OFFICE OF ACQ GRANT SVCS

Office:

FDA OFFICE OF ACQ GRANT SVCS

All Dates/Times are:

(utc-05:00) eastern standard time, new york, usa

Updated Published Date:

(utc-05:00) eastern standard time, new york, usa

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

jan 12, 2022 04:00 pm est

Inactive Policy:

15 days after date offers due

Original Inactive Date:

jan 27, 2022

Initiative:

• None***--***

Product Service Code:

7a21 - it and telecom it and telecom

NAICS Code:

541519 - other computer related services

Original Set Aside:

The primary objective is to procure a cloud based mentoring platform that can accommodate up to 15,000 users, maintenance support, and training on a firm fixed price bases, for the MentorcliQ platform, brand name or equal. This is a combined/synopsis solicitation issued under FAR Part 12 and 13.5 procedures. This is an unrestricted procurement. The NAICS code is 541519. Quoters shall certify their quotes to be valid for at least 30 days. Quoters shall submit a quote for all requirements listed in this RFQ. Partial quotes will not be considered. Incomplete pricing or pricing with omissions may not be considered for award. Quoters shall submit all assumptions in their quotation. Quoters are advised that additional terms and conditions submitted with their quotation that is in conflict of the terms and conditions of this solicitation may be deems as technically unacceptable and may not be considered for award. All additional terms and conditions must be submitted with its quotation. The quote shall contain sufficient information to allow the Government to determine whether the quote is meeting all the requirements in the SOW. Quoters providing quotations must clearly state the overall cost to the Government. Quoters shall ensure that their initial submission represents their best pricing and that all information is provided to determine technical acceptability. The Government will not research items to determine compatibility; all information regarding compatibility must be contained within the quotation. Equal To quotes must meet all the salient characteristics in order to be considered technically acceptable. Equal to quotes must submit a separate Technical Quote with a detailed point-by-point description of how the Equal To products meet all the salient characteristics of this SOW. Equal to Quotes shall be required to operate seamlessly with all requirements out lined in Section 2 of this solicitation. Simiply returning the solicitation may deem your quote to be non responsive. Regeratation of the requirements out lined in Section 2 may be deemed technically unacceptable. Quotes providing the brand name product are not required to submit separate Technical Quotes. Technical Quotes shall not contain pricing information. Equal To quotes shall include a breakdown of all costs associated with the integration of the proposed solution into FDA environment. These costs shall be incorporated in the overall cost to the Government. For equal to quotations, Quoters will submit Section 508 Product Accessibility Templates (PAT) in full text with their quotations. For more information regarding PATs see: https://www.hhs.gov/web/section-508/contracting/technology-products/product-accessiblity-template/ If Quoters fail to address this Section 508 PAT in their quotes, they may be deemed non-responsive and not considered for award. Please submit questions to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by January 7, 2021, 4PM Eastern Time. Please submit quotes to Min Jie (Terry) Zeng via email at minjie.zeng@fda.hhs.gov by January 12, 2021, 4PM Eastern Time.

4041 Powder Mill Road 4th Floor

Beltsville , MD 20705

USA

Primary Point of Contacts:

Min Jie Zeng